STAT

‘We are increasingly exposed’: New studies show how easy it is to identify people using genetic databases

Even if your genetic information isn't linked to your name and address, it might not be as anonymous as you think. Two new studies show just how easy it is…
A San Francisco Police Department wanted bulletin and copies of letters sent to the San Francisco Chronicle by a man who called himself Zodiac. Detectives in Northern California are trying to get a DNA profile on the Zodiac Killer to track him down using the same family-tree tracing technology investigators used in the Golden State Killer case. Source: Eric Risberg/AP

In recent months, consumer genealogy websites have unleashed a revolution in forensics, allowing law enforcement to use family trees to track down the notorious Golden State Killer in California and solve other cold cases across the country. But while the technique has put alleged killers behind bars, it has also raised questions about the implications for genetic privacy.

According to a pair of studies published Thursday, your genetic privacy may have already eroded even further than previously realized.

In an analysis , researchers used a database run by the genealogy company MyHeritage to look at the genetic

Stai leggendo un'anteprima, registrati per continuare a leggere.

Altro da STAT

STAT1 min lettiMedical
STAT+: Pharmalittle: U.S. Considers Giving Half-doses Of Moderna Vaccine; Americans May Not Get AstraZeneca Shot Until April
The U.S. government is considering giving some people half the dose of the Moderna Covid-19 vaccine in order to speed vaccinations.
STAT1 min letti
STAT+: Pharmalittle: Hospitals Grapple With Extra Dose Of Pfizer Vaccine; FDA Panel Meets To Review Moderna Vaccine
With the Covid-19 vaccine in short supply, hospital pharmacists found themselves throwing away one in every six doses of the first vaccines distributed this week in the U.S.
STAT1 min lettiMedical
STAT+: Pharmalittle: Novavax Faces Raw-materials Shortages For Covid-19 Shot; India Curbs Vaccine Exports
Novavax is delaying signing a contract to supply its Covid-19 vaccine to the European Union because the company is struggling to source raw materials.